Search

Search results

3013 results found

Proactive Therapeutic Drug Monitoring Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease Treated With Intravenous Vedolizumab.

Porth, Rachel, Tina Deyhim, Samantha Zullow, Loren G Rabinowitz, Laurie B Grossberg, Xavier Roblin, Stephane Paul, Adam S Cheifetz, and Konstantinos Papamichael. 2025. “Proactive Therapeutic Drug Monitoring Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease Treated With Intravenous Vedolizumab.”. Inflammatory Bowel Diseases 31 (2): 485-91.

Higher Adalimumab Concentration Is Associated With Complete Fistula Healing in Patients With Perianal Fistulizing Crohn's Disease.

Papamichael, Konstantinos, Andrea Centritto, Lucas Guillo, Jessica Hier, Zachary Sherman, Adam S Cheifetz, and International Consortium of Therapeutic Drug Monitoring. 2024. “Higher Adalimumab Concentration Is Associated With Complete Fistula Healing in Patients With Perianal Fistulizing Crohn’s Disease.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 22 (10): 2134-2136.e2.

Higher Serum Infliximab Concentrations Following Subcutaneous Dosing are Associated with Deep Remission in Patients with Inflammatory Bowel Disease.

Roblin, Xavier, Stéphane Nancey, Konstantinos Papamichael, Gérard Duru, Mathurin Flamand, Sandy Kwiatek, Adam Cheifetz, Nicole Fabien, Mathilde Barrau, and Stephane Paul. 2024. “Higher Serum Infliximab Concentrations Following Subcutaneous Dosing Are Associated With Deep Remission in Patients With Inflammatory Bowel Disease.”. Journal of Crohn’s & Colitis 18 (5): 679-85.